Agilent Technologies Announces Efforts to Streamline High-Throughput Sequencing

Agilent Technologies Inc. (NYSE: A) today announced that findings stemming from the use of a novel method to further increase the value of high-throughput DNA sequencing were presented at the Advances in Genome and Biology Technology (AGBT) conference. The method combines oligonucleotide libraries developed by Agilent with the Broad Institute of MIT and Harvard’s production scale sequencing expertise, creating an efficient and highly multiplexed technique to capture targets for sequencing from genomic DNA.

Source: Agilent Technologies